Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.

Saved in:
Bibliographic Details
Title: Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.
Authors: Abuhelwa AY; College of Pharmacy, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae., Almansour SA; College of Pharmacy, University of Sharjah, Sharjah, UAE., Al-Shamsi HO; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, P.O. Box 92510, Abu Dhabi, UAE.; Emirates Oncology Society, P.O.Box: 6600, Dubai, UAE.; College of Medicine, Ras Al Khaimah Medical and Health Sciences, Ras Al Khaimah, UAE.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Abuhelwa Z; Department of Hematology and Medical Oncology, University of South Florida/ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA., Alqudah MAY; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Bustanji Y; College of Medicine, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, the University of Jordan, Amman, Jordan., Semreen MH; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE., Alzoubi KH; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan., Modi ND; Clinical and Health Sciences, University of South Australia, Adelaide, Australia., McKinnon RA; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
Source: Scientific reports [Sci Rep] 2026 Feb 07; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 07.
Publication Type: Journal Article; Clinical Trial, Phase III
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41651961
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Abuhelwa+AY%22">Abuhelwa AY</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE. Ahmad.Abuhelwa@sharjah.ac.ae.<br /><searchLink fieldCode="AU" term="%22Almansour+SA%22">Almansour SA</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.<br /><searchLink fieldCode="AU" term="%22Al-Shamsi+HO%22">Al-Shamsi HO</searchLink>; Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, P.O. Box 92510, Abu Dhabi, UAE.; Emirates Oncology Society, P.O.Box: 6600, Dubai, UAE.; College of Medicine, Ras Al Khaimah Medical and Health Sciences, Ras Al Khaimah, UAE.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Abuhelwa+Z%22">Abuhelwa Z</searchLink>; Department of Hematology and Medical Oncology, University of South Florida/ H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA.<br /><searchLink fieldCode="AU" term="%22Alqudah+MAY%22">Alqudah MAY</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Bustanji+Y%22">Bustanji Y</searchLink>; College of Medicine, University of Sharjah, Sharjah, UAE.; Faculty of Pharmacy, the University of Jordan, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Semreen+MH%22">Semreen MH</searchLink>; College of Pharmacy, University of Sharjah, Sharjah, UAE.; Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, UAE.<br /><searchLink fieldCode="AU" term="%22Alzoubi+KH%22">Alzoubi KH</searchLink>; College of Pharmacy, QU Health, Qatar University, Doha, Qatar.; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.<br /><searchLink fieldCode="AU" term="%22Modi+ND%22">Modi ND</searchLink>; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22McKinnon+RA%22">McKinnon RA</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Sorich+MJ%22">Sorich MJ</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Hopkins+AM%22">Hopkins AM</searchLink>; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2026 Feb 07; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41651961
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-026-37464-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Abuhelwa AY
      – PersonEntity:
          Name:
            NameFull: Almansour SA
      – PersonEntity:
          Name:
            NameFull: Al-Shamsi HO
      – PersonEntity:
          Name:
            NameFull: Abuhelwa Z
      – PersonEntity:
          Name:
            NameFull: Alqudah MAY
      – PersonEntity:
          Name:
            NameFull: Bustanji Y
      – PersonEntity:
          Name:
            NameFull: Semreen MH
      – PersonEntity:
          Name:
            NameFull: Alzoubi KH
      – PersonEntity:
          Name:
            NameFull: Modi ND
      – PersonEntity:
          Name:
            NameFull: McKinnon RA
      – PersonEntity:
          Name:
            NameFull: Sorich MJ
      – PersonEntity:
          Name:
            NameFull: Hopkins AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 02
              Text: 2026 Feb 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1